HIPEC Explained: Heated Chemotherapy During Surgery for Ovarian Cancer
- 21 hours ago
- 2 min read
Darling A, Harlev C, O’Cearbhaill R . Use of hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer: A multidisciplinary review. Surgical Oncology Insight, 2026; 3
What is this study about?
This article looks at a treatment called HIPEC (Hyperthermic Intraperitoneal Chemotherapy).
HIPEC is given during surgery for cancers that have spread inside the abdomen (like ovarian cancer).
Doctors circulate warm chemotherapy directly in the belly to kill cancer cells that may be left behind.
The goal of the study is to explain how HIPEC works, when it may help, and what we currently know about its benefits and risks.
Why is this important?
Ovarian cancer often spreads inside the abdomen (called the “peritoneal cavity”). This can make it harder to treat because:
Tiny cancer cells may remain after surgery
Standard chemotherapy (given through the bloodstream) may not reach all these areas
HIPEC is designed to:
Deliver high doses of chemotherapy directly where the cancer is
Use heat to help the drug work better and penetrate tissues more deeply
Reduce exposure to the rest of the body, potentially limiting side effects
How does HIPEC work?
During surgery:
Surgeons remove as much visible cancer as possible
Heated chemotherapy is circulated inside the abdomen for a set time
The drug targets any remaining cancer cells
The heat helps chemotherapy be more effective at killing cancer cells.
What did the research find?
Potential benefits
Some studies show longer survival and delayed cancer recurrence when HIPEC is added to surgery
It may be especially helpful in certain situations, such as:
After initial chemotherapy
When most visible tumor can be removed
Safety
In many studies, side effects and complications were similar to surgery without HIPEC
However, HIPEC is still a complex procedure and requires experienced medical teams
What are the limitations?
Results are not consistent across all patients or settings
Not everyone benefits equally—patient selection matters
More research is needed to:
Identify who benefits most
Standardize how HIPEC is given
What does this mean for patients?
HIPEC is a promising treatment option, but it is not standard for everyone
It is usually considered in specialized centers and for carefully selected patients
Patients should talk with their care team about:
Whether HIPEC is appropriate for their situation
The potential risks and benefits
Bottom line
HIPEC is an advanced treatment that delivers heated chemotherapy directly into the abdomen during surgery. It may improve outcomes for some people with ovarian cancer, but it is still being studied to better understand who benefits most and how to use it safely and effectively.
